Decentralised molecular diagnostics networks are transforming epidemiological surveillance. By integrating portable PCR and cloud-based data analysis platforms, it is possible to monitor the spread of pathogens in real time and intervene early to contain outbreaks and strengthen health preparedness.

Multiplex PCR allows multiple molecular targets to be detected simultaneously in a single test. This article describes how innovations in multiplex PCR evolve from the applied research phase to become commercial diagnostic solutions, through successive stages of scientific validation, industrial development and regulatory compliance.

In health emergencies, reporting time is a decisive factor: delays of even a few hours can turn an outbreak into an out-of-control crisis. Decentralised PCR – thanks to portable devices, ambient-stable reagents and cloud platforms – brings laboratory accuracy to the field, enabling immediate triage and real-time surveillance. The article explores operational benefits and application scenarios, highlighting the value of integrated solutions such as Hyris System™ (bCUBE™, bAPP™).

From the integration of Ulisse Biomed and Hyris to the rebranding that consolidated the Helyx identity and the new industrial structure with three complementary divisions (Hyris, Vytro, Mytho). Interview with Nicola Basile — CEO of Helyx Industries S.p.A.